In this webinar, Dr. Yassen Abbas will discuss how CN-Bio’s gut-liver MPS can be used for in vitro determination of oral bioavailability. This application has been validated with drugs with known human bioavailability and with a mathematical model developed to enable prediction of oral bioavailability in silico.
Bioengineer
CN Bio
Watch this webinar to learn:
Bioavailability is a key parameter of a drug’s behaviour and is determined during pre-clinical development. It is the fraction of a compound that reaches systemic circulation and is important for efficacy and safety considerations. Bioavailability estimations to date have relied heavily on animal models, however, these models are expensive and have limited relevance to humans.
Visit cn-bio.com for more information & news
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563
For all the latst news visit our news section here
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563